ワシントンにおける心血管疾患の臨床試験
ワシントン内の拠点で、心血管疾患に関する15件の研究が参加者を募集しています。
ワシントン内の都市
公式研究テキスト（英語）
ELEVATE-HFpEF Clinical Study
- Saint Joseph Medical Center (Tacoma WA), Tacoma
被験者募集中
40歳以上 · 全性別 · 2026/10/02更新 · NCT06678841EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Universal Research Group, LLC, Tacoma
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- MultiCare Institute for Research and Innovation, Puyallup
- MultiCare Institute for Research and Innovation, Tacoma
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06909565A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Eastside Research Associates, Redmond
被験者募集中第3相
45歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07613294Product Surveillance Registry
- Bremerton
- Seattle
- Spokane
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/18更新 · NCT01524276Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Bellevue
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07181109Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- University of Washington (UW) Medical Center, Seattle
- Providence Sacred Heart Medical Center & Children's Hospital, Spokane
被験者募集中
18歳以上 · 全性別 · 2026/09/15更新 · NCT03242642An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Harborview Medical Center, Seattle
- Swedish Medical Center-Cardiovascular Research, Seattle
- Univ of Washington Medical Center, Seattle
被験者募集中第3相
18歳〜100歳 · 全性別 · 2026/09/04更新 · NCT07517263A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
- Seattle Children's Hospital, Seattle
被験者募集中観察研究
7歳以上 · 全性別 · 2026/08/25更新 · NCT05705531A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Puyallup
- Research Site, Redmond
- Research Site, Renton
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/24更新 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Western Washington Medical Group, Everett
- Rainier Clinical Research Center, Renton
被験者募集中第3相
50歳〜105歳 · 全性別 · 2026/08/21更新 · NCT07136012Global Paradise System US Post Approval Study
- Swedish Medical Center, Seattle
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/12更新 · NCT06297291PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Providence Everett, Everett
被験者募集中
18歳以上 · 全性別 · 2026/06/29更新 · NCT05934487Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/03/24更新 · NCT06217302MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
被験者募集中第1相
12歳〜25歳 · 全性別 · 2025/06/13更新 · NCT05065372ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。